British Columbia Investment Management’s Idexx Laboratories IDXX Stock Holding History

British Columbia Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.18M	Sell	11,006 -3,168	-22%	-$2.03M	0.04%	327
2025 Q4	$9.59M	Buy	14,174 +2,615	+23%	+$1.78M	0.05%	277
2025 Q3	$7.38M	Sell	11,559 -1,191	-9%	-$723K	0.04%	291
2025 Q2	$6.84M	Sell	12,750 -2,910	-19%	-$1.39M	0.04%	303
2025 Q1	$6.58M	Sell	15,660 -100	-0.6%	-$43.4K	0.04%	332
2024 Q4	$6.52M	Buy	15,760 +1,980	+14%	+$868K	0.04%	346
2024 Q3	$6.96M	Sell	13,780 -2,134	-13%	-$1.04M	0.04%	305
2024 Q2	$7.75M	Buy	15,914 +5,998	+60%	+$3.01M	0.05%	290
2024 Q1	$5.35M	Buy	9,916 +357	+4%	+$195K	0.04%	313
2023 Q4	$5.31M	Buy	9,559 +2,014	+27%	+$946K	0.04%	289
2023 Q3	$3.3M	Buy	7,545 +63	+0.8%	+$31.4K	0.03%	346
2023 Q2	$3.76M	Buy	7,482 +87	+1%	+$41.7K	0.04%	321
2023 Q1	$3.7M	Hold	7,395	–	–	0.04%	316
2022 Q4	$3.02M	Sell	7,395 -915	-11%	-$355K	0.03%	355
2022 Q3	$2.71M	Sell	8,310 -1,467	-15%	-$539K	0.03%	386
2022 Q2	$3.43M	Sell	9,777 -3,314	-25%	-$1.35M	0.03%	373
2022 Q1	$7.16M	Sell	13,091 -1,858	-12%	-$977K	0.05%	310
2021 Q4	$9.84M	Sell	14,949 -839	-5%	-$527K	0.06%	284
2021 Q3	$9.82M	Sell	15,788 -15	-0.1%	-$10.1K	0.06%	278
2021 Q2	$9.98M	Buy	15,803 +1,803	+13%	+$996K	0.06%	283
2021 Q1	$6.85M	Sell	14,000 -371	-3%	-$186K	0.05%	308
2020 Q4	$7.18M	Sell	14,371 -359	-2%	-$161K	0.05%	292
2020 Q3	$5.79M	Buy	14,730 +1,056	+8%	+$390K	0.05%	306
2020 Q2	$4.51M	Buy	13,674 +4,288	+46%	+$1.24M	0.04%	323
2020 Q1	$2.27M	Sell	9,386 -10,900	-54%	-$2.84M	0.04%	336
2019 Q4	$5.3M	Buy	20,286 +630	+3%	+$166K	0.04%	353
2019 Q3	$5.34M	Sell	19,656 -7,292	-27%	-$2.03M	0.05%	372
2019 Q2	$7.42M	Sell	26,948 -8,028	-23%	-$1.98M	0.06%	323
2019 Q1	$7.82M	Sell	34,976 -8,059	-19%	-$1.66M	0.07%	305
2018 Q4	$8.01M	Sell	43,035 -7,876	-15%	-$1.61M	0.07%	281
2018 Q3	$12.7M	Sell	50,911 -13,339	-21%	-$3.24M	0.13%	168
2018 Q2	$14M	Buy	64,250 +17,481	+37%	+$3.6M	0.12%	185
2018 Q1	$8.95M	Sell	46,769 -5,612	-11%	-$1.04M	0.07%	334
2017 Q4	$8.19M	Sell	52,381 -40,051	-43%	-$6.3M	0.06%	377
2017 Q3	$14.4M	Sell	92,432 -3,000	-3%	-$474K	0.11%	231
2017 Q2	$15.4M	Buy	95,432 +60,859	+176%	+$9.88M	0.12%	210
2017 Q1	$5.34M	Buy	34,573 +4,793	+16%	+$661K	0.04%	460
2016 Q4	$3.49M	Sell	29,780 -10,583	-26%	-$1.21M	0.03%	552
2016 Q3	$4.55M	Buy	40,363 +5,033	+14%	+$530K	0.05%	460
2016 Q2	$3.28M	Buy	+35,330	New	+$3.03M	0.03%	549
2015 Q1	–	Sell	-18,820	Closed	-$1.4M	–	746
2014 Q4	$1.4M	Hold	18,820	–	–	0.01%	606
2014 Q3	$1.11M	Hold	18,820	–	–	0.01%	604
2014 Q2	$1.26M	Sell	18,820 -1,066	-5%	-$67.8K	0.01%	603
2014 Q1	$1.21M	Hold	19,886	–	–	0.01%	601
2013 Q4	$1.06M	Buy	19,886 +766	+4%	+$40.3K	0.01%	605
2013 Q3	$953K	Buy	19,120 +648	+4%	+$31.1K	0.01%	611
2013 Q2	$828K	Buy	+18,472	New	+$807K	0.01%	614

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

British Columbia Investment Management's IDXX Position: Q1 2026 in Review

British Columbia Investment Management reduced its Idexx Laboratories (IDXX) stake by 22% in Q1 2026, selling an estimated $2.03M and leaving 11,006 shares worth $6.18M. The position accounts for 0.04% of the portfolio, ranked #327.

British Columbia Investment Management first reported a position in IDXX in Q2 2013 and has held it in 47 quarters since. The position peaked at $15.4M in Q2 2017. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

British Columbia Investment Management held 11,006 shares of Idexx Laboratories worth $6.18M as of Q1 2026.
British Columbia Investment Management sold 3,168 Idexx Laboratories shares in Q1 2026, an estimated $2.03M.
Idexx Laboratories made up 0.04% of British Columbia Investment Management's portfolio in Q1 2026, its #327 holding.
British Columbia Investment Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 47 quarters since.
British Columbia Investment Management's Idexx Laboratories position peaked at $15.4M in Q2 2017.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on British Columbia Investment Management's 13F filing for Q1 2026, filed 14 May 2026.